Payment for drug therapy.
This regular column of Physician Executive deals with the issues surrounding expanding technology in the delivery of health care services. Although technology is most commonly viewed in terms of equipment and procedures, the growing cost and complexity of drug therapy has made even this technology the target of assessment. The following report details the positions taken by the buyers of health care services on payment for drug therapy.
McGivney
W T
WT
American Medical Association, Chicago, IL.
D000574:American Medical Association; D014487:Centers for Medicare and Medicaid Services, U.S.; D015507:Drugs, Investigational / Q000627:therapeutic use*; D007356:Insurance, Pharmaceutical Services; D014481:United States; D014486:United States Food and Drug Administration
D015507:Drugs, Investigational